Spending on cancer treatment has been skyrocketing globally. According to the IMS Institute of Health, spending on cancer topped $100 billion globally in 2014. That was a 10% increase from 2013.
That's why many biotech stocks tied to cancer treatments have seen triple-digit gains in the last two years.
by Jim Bach
It's been a wild ride for International Business Machines Corp. (NYSE: IBM) stock this year.
Wall Street simply doesn't know what to do with this enterprise solutions giant.
But should you buy it now while it's down? Here's what to consider...
by Diane Alter
Up 4.2% year to date, silver prices could end the year solidly higher.
There are a handful of catalysts that can push up the white metal.
Keep reading for why the silver price forecast sees higher prices ahead...
by Alex McGuire
There are 16 companies on this week's upcoming IPO calendar, expected to raise a combined $2.49 billion.
This should be the IPO market's most active week of the year.
by Jim Bach
If you're looking to strike it rich with pot stocks, we may have some bad news for you.
Unless you are an angel investor, friends and family of a promising startup, or a lucky pump-and-dumper, it's next to impossible to be a successful pot stock investor.
But there are a few things you can do now in an investing environment unfriendly to pot stocks...
by David Zeiler
As the financial crisis in Greece intensifies, it serves as a reminder to investors everywhere of the importance of knowing the best investments for keeping your assets safe.
You never know when some sort of financial tragedy will strike, so it pays to be prepared.
Here's a look at several of the best investments for a crisis and the strengths of each...
Futures for the DJIA today forecasted a 114-point gain from Friday's close.
On Friday, the DJIA fell 101 points as investors weighed ongoing debt drama in Greece. The markets were also victim to quadruple witching, a period when volatility often spikes in the final trading hour thanks to the expiration of options and futures contracts.
Here's everything else you need to know about the DJIA today...
The central bank circus was on full display this week as the Federal Reserve's Open Market Committee held a two-day meeting only to emerge with another mind-numbing series of excuses for keeping interest rates at zero when the economy is not in crisis.
One such claim was that inflation (as measured by economists) is insufficiently high, despite the fact that the price of real-world goods and services (including gasoline again) are steadily rising. The Fed stated that it's afraid raising interest rates – for the first time in nine years by all of 25 basis points – could send the economy into a tailspin. That isn't only bad policy, it is pathetic.
Perhaps it is time we learned this one vital lesson...
by Jim Bach
On May 30, 2015, former Maryland governor Martin O’Malley announced his candidacy for the Democratic presidential nomination in 2016.
The progressive icon stands to the left of the poll-leading Democrat Hillary Clinton and has found a niche in painting himself as the populist hero in contrast to Clinton’s Wall Street ties and far-ranging donor pool of “one-percenters.”
What happened to the Dow Jones today?
Get final numbers, stocks to watch, biggest news, and today's best profit plays.
